Joint research at Kumamoto University in Japan discovered a new mechanism for anticancer drug resistance in gastric cancer. Experiments clarified that the Annexin A6 molecule contained in extracellular vesicles (EVs) is secreted by cancer-associated fibroblasts (CAFs) and taken up by gastric cancer cells, resulting in resistance to anticancer drug treatment. New drug development that targets Annexin A6 and cancer-associated fibroblasts (CAFs) may be possible.
- Volunteers receiving government aid while unemployed face scrutiny, bias from public
- The testimony of trees: How volcanic eruptions shaped 2000 years of world history
- Building walls that will make summer heat waves more bearable
- How hormone therapy slows progression of atherosclerosis
- Could your menopause symptoms be hard on your heart?